×î´ó×ÊÔ´²É¼¯Íø

Palm Health Foundation has pledged $500,000 toward the launch of the Center for the Resilient Mind at ×î´ó×ÊÔ´²É¼¯Íø's Stiles-Nicholson Brain Institute (SNBI).

FAU's Charles E. Schmidt College of Medicine recently hosted the summit, bringing together top scientists from North America and Europe to discuss the latest amyloid research and advancements.

A breakthrough by FAU researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.

FAU Jupiter’s Multi-institute Research Hub Hosts Joint Event to Celebrate Biomedical Research Driven by the Next Generation of Scientists

Stiles-Nicholson Brain Institute Marks Opening of Neurodegenerative Disease Research Center

×î´ó×ÊÔ´²É¼¯Íø's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.

FAU researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.

FAU neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.

Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.

FAU has added a new state-of-the-art MRI system to its research infrastructure, marking a transformative step forward for groundbreaking studies in neuroscience, clinical health and medical advancements.